150 related articles for article (PubMed ID: 33651134)
1. Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities.
Hashimoto R; Numasawa Y; Yokokura S; Daigo K; Sakata S; Imaeda S; Hitomi Y; Sato K; Taruoka A; Haginiwa S; Kojima H; Tanaka M; Kuno T; Kodaira M
Heart Vessels; 2021 Sep; 36(9):1350-1358. PubMed ID: 33651134
[TBL] [Abstract][Full Text] [Related]
2. Bleeding events and mid-term mortality in the patients undergoing endovascular interventions for peripheral artery disease of the lower limbs based on the academic research consortium high bleeding risk criteria.
Yoshioka N; Takagi K; Morita Y; Kanzaki Y; Nagai H; Watanabe N; Morishima I
Heart Vessels; 2021 Sep; 36(9):1336-1349. PubMed ID: 33616719
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in patients undergoing peripheral endovascular interventions.
Tomoi Y; Kuramitsu S; Shinozaki T; Soga Y; Kodama K; Imada K; Hiramori S; Ando K
EuroIntervention; 2023 Apr; 18(16):e1368-e1377. PubMed ID: 36579610
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes Based on High Bleeding Risk in Patients With Lower Extremity Peripheral Artery Disease Who Have Undergone Endovascular Therapy.
Yoshioka N; Tokuda T; Koyama A; Yamada T; Shimamura K; Nishikawa R; Morita Y; Morishima I
J Endovasc Ther; 2023 May; ():15266028231176953. PubMed ID: 37246791
[TBL] [Abstract][Full Text] [Related]
5. Two-year outcomes of endovascular therapy for femoropopliteal arterial lesions for patients with high bleeding risk.
Shima Y; Taninobu N; Ikuta A; Mushiake K; Tanaka H; Kadota K
Cardiovasc Interv Ther; 2024 Jul; 39(3):284-292. PubMed ID: 38630431
[TBL] [Abstract][Full Text] [Related]
6. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
[TBL] [Abstract][Full Text] [Related]
7. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
[TBL] [Abstract][Full Text] [Related]
8. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
[TBL] [Abstract][Full Text] [Related]
9. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.
Nakamura M; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Iijima R; Harada A; Kuroda T; Murakami Y
EuroIntervention; 2021 Feb; 16(14):1154-1162. PubMed ID: 32624464
[TBL] [Abstract][Full Text] [Related]
10. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
[TBL] [Abstract][Full Text] [Related]
12. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-3.
Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.
Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A
J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
[TBL] [Abstract][Full Text] [Related]
16. Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction.
Nicolas J; Beerkens F; Cao D; Sartori S; Pivato CA; Qiu H; Giustino G; Chiarito M; Claessen BE; Zhang Z; Nardin M; Razuk V; Jones D; Camaj A; Power D; Banashefski B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
J Thromb Thrombolysis; 2022 Jan; 53(1):20-29. PubMed ID: 34347202
[TBL] [Abstract][Full Text] [Related]
17. Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria.
Spirito A; Gragnano F; Corpataux N; Vaisnora L; Galea R; Svab S; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Capodanno D; Urban P; Pocock S; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
J Am Heart Assoc; 2021 Jun; 10(12):e021965. PubMed ID: 34098740
[TBL] [Abstract][Full Text] [Related]
18. Association between High Bleeding Risk and 2-Year Mortality in Patients with Chronic Limb-Threatening Ischemia.
Yoshioka N; Tokuda T; Koyama A; Yamada T; Shimamura K; Nishikawa R; Morita Y; Morishima I
J Atheroscler Thromb; 2023 Nov; 30(11):1674-1686. PubMed ID: 36948637
[TBL] [Abstract][Full Text] [Related]
19. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
[TBL] [Abstract][Full Text] [Related]
20. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G
Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]